Identification of a presynaptic cannabinoid CB1 receptor in the guinea-pig atrium and sequencing of the guinea-pig CB1 receptor

Journal of Physiology and Pharmacology

Volumn 59, Issue 1, 2008, Pages 3-15

  Kurz, C M ^a   Gottschalk, C ^a   Schlicker, Eberhard ^a   Kathmann, M ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Guinea pig atrium; Guinea pig CB1 receptor sequence; Guinea pig kidney; Noradrenaline release; Presynaptic receptors

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; NORADRENALIN; OXOTREMORINE; PROSTAGLANDIN E2; RIMONABANT;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GUINEA PIG; HEART ATRIUM; HUMAN; INNERVATION; KIDNEY CORTEX; MALE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NORADRENALIN RELEASE; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; RAT; SEQUENCE HOMOLOGY; SYMPATHETIC NERVE CELL;

AMINO ACID SEQUENCE; ANIMALS; ELECTRIC STIMULATION; GUINEA PIGS; HEART ATRIA; KIDNEY CORTEX; MALE; MOLECULAR SEQUENCE DATA; NEURONS; NOREPINEPHRINE; RECEPTOR, CANNABINOID, CB1; SEQUENCE ANALYSIS, PROTEIN; SPECIES SPECIFICITY; SYMPATHETIC NERVOUS SYSTEM;

EID: 42049089928     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. nd edition (2007 revision). Br J Pharmacol 2007; 150 (Suppl 1): S1-S168.
2. Pacher P, Batkai S, Kunos G. Cardiovascular pharmacology of cannabinoids. Handb Exp Pharmacol 2005; 168: 599-625.
3. Szabo B, Schlicker E. Effects of cannabinoids on neurotransmission. Handb Exp Pharmacol 2005; 168: 327-365.
4. 1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 1997; 356: 583-589.
5. 1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels but not in rat and mouse aorta. Naunyn-Schmiedeberg's Arch Pharmacol 2005; 372: 139-146.
6. 1 receptors on periphal sympathetic nerves. Br J Pharmacol 1996; 18: 2023-2028.
7. 1 receptors in the rat and mouse. Eur J Pharmacol 2000; 391: 151-161.
8. 3H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and β-adrenoceptors in mouse tissues. Br J Pharmacol 2000; 130: 321-330.
9. 1 receptors increases noradrenaline release in vas deferens without affecting atrial noradrenaline release or cortical acetylcholine release. Br J Pharmacol 2003; 140: 323-328.
10. Lindmar R, Löffelholz K, Muscholl E. A muscarinic mechanism inhibiting the release of noradrenaline from peripheral adrenergic nerve fibres by nicotinic agents. Br J Pharmacol 1968; 32: 280-294.
11. Mantelli L, Amerini S, Ledda F. Different effects of prostaglandins on adrenergic neurotransmission in atrial and ventricular preparations. Br J Pharmacol 1990; 99: 717-720.
12. 3 subtype. Pharmacology 1995; 51: 112-117.
13. 2- adrenoceptors by isoprenaline and adrenaline enhances noradrenaline release in cortical kidney slices of young spontaneously hypertensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 1992; 345: 25-32.
14. Schlicker E, Göthert M. Interactions between the presynaptic α2-autoreceptors and presynaptic inhibitory heteroreceptors on noradrenergic neurones. Brain Res Bull 1998; 47: 129-132.
15. Pertwee RG. Pharmacological actions of cannabinoids. Handb Exp Pharmacol 2005; 168: 1-51.
16. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 1977; 77: 1-124.
17. Molderings GJ, Likungu J, Göthert M. Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship. Naunyn-Schmiedeberg's Arch Pharmacol 1999; 360: 157-164.
18. Schultheiß T. Modulation der Neurotransmitterfreisetzung durch Cannabinoide und andere präsynaptisch angreifende Liganden. Thesis, University of Bonn 2005.
19. Deutsch DG, Goligorsky MS, Schmid PC, et al. Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 1997; 100: 1538-1546.
20. Schlicker E, Timm J, Göthert M. Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn-Schmiedeberg's Arch Pharmacol 1996; 354: 791-795.
21. Coutts A, Pertwee RG. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br J Pharmacol 1997; 121: 1557-1566.
22. 1 receptors in guinea-pig small intestine. Br J Pharmacol 1996; 118: 2199-2205.
23. 1 receptors. Br J Pharmacol 1998; 124: 1363-1368.
24. Lan R, Liu Q, Fan P, et al. Structure-activity relationship of pyrazole derivates as cannabinoid receptor antagonists. J Med Chem 1999; 42: 769-776.
25. 1 receptor-mediated inhibition of noradrenaline release in the guinea-pig lung. Eur J Pharmacol 2001; 431: 237-244.
26. Murphy WJ, Eizirik E, Johnson WE, Zhang YP, Ryder OA, O'Brien SJ. Molecular phylogenetics and the origins of placental mammals. Nature 2001; 409: 614-618.
27. Abood ME. Molecular biology of cannabinoid receptors. Handb Exp Pharmacol 2005; 168: 81-115.
28. Gerard C, Mollereau C, Vassart G, Parmentier M. Nucleotide sequence of a human cannabinoid receptor cDNA. Nucleic Acid Res 1990; 18: 7142.
29. Chakrabarti A, Onaivi ES, Chaudhuri G. Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein. DNA Seq 1995; 5: 385-388.
30. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561-564